A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

May 31, 2005

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

Gemcitabine

DRUG

docetaxel

DRUG

cisplatin

Trial Locations (1)

50019

For additional information regarding investigative sites for this trial, please call 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Monday-Friday, 9:00 am to 5:00 pm Eastern time (UTC/GMT - 5 hours, EST) or speak with your physician, Sesto Fiorentino

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY